Skip to main content

. 1996 Nov 30;313(7069):1369–1370. doi: 10.1136/bmj.313.7069.1369

NHS breast screening programme: is the high incidence of interval cancers inevitable?

D Asbury ¹, C R Boggis ¹, D Sheals ¹, A G Threlfall ¹, C B Woodman ¹

PMCID: PMC2352925 PMID: 8956704

1370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Day N., McCann J., Camilleri-Ferrante C., Britton P., Hurst G., Cush S., Duffy S. Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme. J Med Screen. 1995;2(4):180–185. doi: 10.1177/096914139500200402. [DOI] [PubMed] [Google Scholar]
Field S., Michell M. J., Wallis M. G., Wilson A. R. What should be done about interval breast cancers? BMJ. 1995 Jan 28;310(6974):203–204. doi: 10.1136/bmj.310.6974.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
Frisell J., von Rosen A., Wiege M., Nilsson B., Goldman S. Interval cancer and survival in a randomized breast cancer screening trial in Stockholm. Breast Cancer Res Treat. 1992;24(1):11–16. doi: 10.1007/BF01832353. [DOI] [PubMed] [Google Scholar]
Peeters P. H., Verbeek A. L., Hendriks J. H., Holland R., Mravunac M., Vooijs G. P. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer. 1989 Jun;59(6):929–932. doi: 10.1038/bjc.1989.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
Woodman C. B., Threlfall A. G., Boggis C. R., Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ. 1995 Jan 28;310(6974):224–226. doi: 10.1136/bmj.310.6974.224. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES